Video Latest - ecancer

Toll like receptor 7 agonists for cancer immunotherapy

Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany

25 Mar 2014

The 1st Immunotherapy of Cancer Conference (ITOC)

Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria

25 Mar 2014

Reasons for combining immunotherapy with chemo to enhance anti tumour response

Prof Angus Dalgleish - St George's, University of London, London, UK

25 Mar 2014

Dendritic cell vaccination combined with CTLA4 blockade

Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium

25 Mar 2014

mRNA-based cancer vaccines

Dr Karl-Josef Kallen - Principal Scientific Fellow, CureVac Gmbh

24 Mar 2014

Cancer cells and the immune system: a natural story?

Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France

3 Dec 2013

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction

Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands

3 Dec 2013

Immuno-Oncology: a concept or already a reality?

Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK

3 Dec 2013

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain

3 Dec 2013

Investigating tumour subtypes of Kaposi's Sarcoma

Dr Aron Abera - MRC/Research Group for Receptor Biology, IIDMM, University of Cape Town, South Africa

2 Dec 2013

Aiding treatment of HIV and cancer with aspirin

Dr Andrew Freedman - National Cancer Institute, Bethesda, USA

27 Nov 2013

HPV prevalence in screened population and types associated with cervix disease

Dr Lesley Anderson - Queens University, Belfast, UK

13 Nov 2013

Video